Evogene, Tel Aviv University Advance AI Drug Discovery
REHOVOT & TEL AVIV, Israel, July 8, 2026 Evogene Ltd. and Tel Aviv University’s Blavatnik Center for Drug Discovery...
collagenase clostridium histolyticum
Advertisement
BioLineRx and Hemispherian Report Promising GLIX1 Ovarian Cancer Data
TEL AVIV, Israel & OSLO, Norway, July 8, 2026 BioLineRx Ltd. and Hemispherian AS have announced encouraging new preclinical...
Keenova Reports Positive Phase 3 Results for XIAFLEX
DUBLIN, Ireland, July 8, 2026 Keenova Therapeutics plc has announced positive Phase 3 clinical trial results for XIAFLEX® (collagenase...
Keenova Highlights Updated XIAFLEX Data for Peyronie’s Disease at AUA 2026
DUBLIN, May 15, 2026 Keenova Therapeutics announced updated clinical findings on XIAFLEX® (collagenase clostridium histolyticum) for the treatment of...
Advertisement
